Ripretinib is an oral bioavailable, selective KIT and PDGFRA inhibitor. Ripretinib also inhibits several other kinase targets, such as FLT3, KDR (VEGFR-2). Ripretinib has antitumor effects and induces apoptosis.
- Size: 1mg
- Purity: ≥98%
- Molecular Formula: C 2 4 H 2 1 BrFN 5 O 2
- Molecular Weight: 510.36
- Physical State: Solid
- Storage: Powder:2-8℃, 2 years;Insolvent(Mother Liquid):-20℃, 6 months;-80℃, 1 year
- Brand: Saint Michael
- Catalogue No.: IR2480-1mg
For laboratory research use only. Not for human or animal consumption, diagnostic or therapeutic use.
Write Your Own Review